PHARMA

AI is transforming pharma.
Biology is the bottleneck.

Human biology meets predictive AI.

Quris combines functional human 3D tissue models with AI to investigate drug safety. Our platform generates experimental evidence and predictive insights to support pharmaceutical development decisions.

A drug molecule approaching a miniaturized human liver tissue construct inside a microfluidic chip
validated with pharma

Validated with Pharma. Built for Real Development Decisions.

Quris collaborates with leading global pharmaceutical companies, including top-10 pharma partners. Our publicly announced relationship with Merck KGaA has progressed from blinded validation to commercial integration, while additional collaborations remain confidential.

Merck KGaA, Darmstadt, Germany

Merck KGaA

Publicly announced collaboration

Additional Top-10 Pharma

Confidential collaborations

The Merck KGaA announcement
  1. Validate

    Blinded evaluation of predictive performance.

  2. Apply

    Drug-safety scanning and analysis.

  3. Expand

    Collaborative development of additional capabilities.

HUMAN-RELEVANT DRUG SAFETY

See How Drugs Affect Human Liver Function

Beyond Cell Viability

Quris measures functional, metabolic and injury-related responses in human 3D liver models. These complementary readouts help build a more complete picture of drug-induced liver effects.

Functional Human Liver Models

Measure drug effects in living human 3D liver tissue.

Dose- and Time-Dependent Responses

Track biological changes across concentrations and exposure periods.

Multiple Biological Readouts

Combine functional and injury-related measurements to investigate safety signals.

A drug candidate producing an early toxicity signal in a living human model
ACROSS THERAPEUTIC MODALITIES

Drug Safety Across Therapeutic Modalities

Different therapeutic modalities raise different safety questions. Quris develops human-relevant experimental approaches tailored to the needs of each program.

Small Molecules

Investigate dose-dependent effects on human liver function and cellular health.

Biologics

Explore safety questions involving biological therapies and human tissue responses.

ADC Payloads

Assess payload-associated toxicity in human tissue models.

PROTACs

Investigate safety effects associated with targeted protein degradation.

Molecular Glues

Study emerging protein degraders using human-relevant experimental approaches.

Immune-Integrated Studies

Explore interactions between immune cells and human liver tissue.

Validation depth differs by modality. Liver safety is Quris's established commercial application; other assays are defined per program.

WHAT PARTNERS RECEIVE

From Biological Data to Development Decisions

Quris delivers quantitative experimental results, AI-supported analysis and scientific interpretation through reports and interactive dashboards.

Quantitative Results

Explore concentration-response relationships and changes over time.

AI-Supported Analysis

Connect measured biological responses with predictive insights.

Interactive Dashboards

Review study results, visualizations and supporting data in one place.

Have a Drug Safety Question?

Explore how Quris can support your development program.